Clariant Partnership Creates Protection In Plastic Medical Devices

Published: Nov 22, 2016

According to the World Health Organisation (WHO), more than 8% of the medical devices in circulation are counterfeit and Interpol estimates USD75 billion of counterfeit pharmaceuticals enter the market every year. Counterfeit medical devices pose a significant liability to their manufacturers and a risk of injury, permanent disability or even death to both patients and healthcare providers. The mission of safe access to treatments remains a challenge to medical devices and pharmaceutical companies despite investments in fighting fakes. As it is well accepted that layers of security are necessary, the features of Plastiward are designed to help with this approach.

Back to news